Clinical trial
Open Label Sumanirole Study of Safety, Tolerability, and Therapeutic Response In…
NCT00036205 · Pfizer, Industry · Terminated
Key facts
| NCT number | NCT00036205 |
|---|---|
| Title | Open Label Sumanirole Study of Safety, Tolerability, and Therapeutic Response In Patients With Parkinson's Disease |
| Official title | Open-Label, Long Term, Flexible Dose Study Of Safety, Tolerability, And Therapeutic Response In Patients With Parkinson's Disease. |
| Lead sponsor | Pfizer, Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Parkinson Disease |
| Intervention type | Drug |
| Interventions | sumanirole |
| Enrollment | 984 |
| Start date | Aug 1, 2000 |
| Completion | Dec 1, 2004 |
| First posted | May 9, 2002 |
| Last update posted | Jan 18, 2007 |
| Countries | Argentina, Colombia, Puerto Rico, United States |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: